WULF - Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.
DouYu plans repurchase of up to $20 million of ordinary shares in the form of ADSS during period of up to twelve months commencing on Jan. 1, 2024.
DouYu International shares jumped 14.2% to $0.8320 on Thursday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Nova LifeStyle, Inc. (NASDAQ: NVFY) shares jumped 204% to $4.71.
- Cingulate Inc. (NASDAQ: CING) climbed 157.4% to $10.27. On Tuesday, Cingulate received FDA guidance for CTx-1301 (dexmethylphenidate), its lead investigational product candidate for attention deficit hyperactivity disorder (ADHD).
- Bone Biologics Corporation (NASDAQ: BBLG) gained 62.2% to $7.54.
- SenesTech, Inc. (NASDAQ: SNES) shares climbed 50.7% to $1.30. HC Wainwright & Co. analyst Amit Dayal maintained SenesTech with a Buy, adjusting target to $3.5 from $4.
- Microbot Medical Inc. (NASDAQ: MBOT) rose 38% to $1.8301 after the company announced the completion of its GLP pivotal pre-clinical study.
- Sidus Space, Inc. (NASDAQ: SIDU) gained 32% to $5.81.
- DatChat, Inc. (NASDAQ: DATS) rose 30% to $2.62. DatChat announced the release of its new AI social gaming platform and developer program for game designers and content creators.
- SEALSQ Corp (NASDAQ: LAES) gained 25% to $1.4424. SEALSQ disclosed that its post-quantum semiconductor technology, based on cutting-edge cryptographic algorithms, is specifically designed to withstand attacks from and secure cryptocurrency transactions against the looming threat of quantum computing.
- Ocean Biomedical, Inc. (NASDAQ: OCEA) surged 21.4% to $0.7299.
- DSS, Inc. (NYSE: DSS) jumped 21% to $0.1477.
- RenovoRx, Inc. (NASDAQ: RNXT) gained 20% to $1.2599.
- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose 20% to $3.6250. The FDA recently approved the company's Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older.
- Envoy ...